Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum

DRUG2 trials

Sponsors

Fudan University

Conditions

Triple-negative Breast Cancer

Phase 2

Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer

RecruitingNCT06355037

Fudan UniversityTriple-negative Breast Cancer

Start: 2024-05-20End: 2025-01-31Target: 10Updated: 2024-07-08

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

CompletedNCT06355024

Fudan UniversityTriple-negative Breast Cancer

Start: 2024-05-11End: 2025-01-01Updated: 2025-07-18